Citation Impact
Citing Papers
Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization
1999 Standout
Transplantation ofex vivoexpanded endothelial progenitor cells for therapeutic neovascularization
2000 Standout
Outcomes of Adults with Acute Lymphoblastic Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation
2013
Enhanced Adherence of Sickle Erythrocytes to Thrombin-Treated Endothelial Cells Involves Interendothelial Cell Gap Formation
1998
Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand
2002 Standout
Duration of Red-Cell Storage and Complications after Cardiac Surgery
2008 Standout
Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors
2001
Hemoglobin disorders and endothelial cell interactions
2009
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
1999 StandoutNature
Erythroid adhesion molecules in sickle cell disease: Effect of hydroxyurea
2008
Tissue factor expression by endothelial cells in sickle cell anemia.
1998
Acute chest syndrome of sickle cell disease: new light on an old problem
2001
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
2007 StandoutNobel
Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes
2005 Standout
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Advances in the diagnosis and therapy of paroxysmal nocturnal hemoglobinuria
2007
Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice
2004
Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice
2010
Imaging in the era of molecular oncology
2008 StandoutNature
Guillain-Barré syndrome
2016 Standout
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice
2000
COVID-19: A review of therapeutic strategies and vaccine candidates
2020
Gene deregulation in gastric cancer
2005
Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model
2008
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
2013 Standout
Guillain–Barré Syndrome
2012 Standout
Preliminary Assessment of Inhaled Nitric Oxide for Acute Vaso-occlusive Crisis in Pediatric Patients With Sickle Cell Disease
2003
Angiogenesis in cancer and other diseases
2000 StandoutNature
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo
2005 StandoutNobel
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Endothelial cell chimerism after renal transplantation and vascular rejection
2001
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Transplanted cord blood–derived endothelial precursor cells augment postnatal neovascularization
2000
Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice
2005
Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: Possible role of TNF-α in endothelial cell damage in dengue
2005
Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
2002
Angiogenesis in life, disease and medicine
2005 StandoutNature
The microenvironment of the tumour–host interface
2001 StandoutNature
Reconstructing sickle cell disease: A data‐based analysis of the “hyperhemolysis paradigm” for pulmonary hypertension from the perspective of evidence‐based medicine
2010
Systemic Lupus Erythematosus
2011 Standout
Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration
2013
Age-related macular degeneration
2018 Standout
Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell Disease
2005
Evidence of Vascular Damage in Dengue Disease: Demonstration of High Levels of Soluble Cell Adhesion Molecules and Circulating Endothelial Cells
2006
Sickle cell disease: no longer a single gene disorder
2001
The multifaceted circulating endothelial cell in cancer: towards marker and target identification
2006
Sickle-cell disease
2010 Standout
An open label clinical trial of complement inhibition in multifocal motor neuropathy
2011
Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk
2003 Standout
Extended storage of red blood cells under anaerobic conditions
2006
Pathophysiological actions of neuropathy‐related anti‐ganglioside antibodies at the neuromuscular junction
2009
Transcoronary Transplantation of Progenitor Cells after Myocardial Infarction
2006 Standout
Idarucizumab for Dabigatran Reversal
2015 Standout
Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients
2011
Stroke risk in siblings with sickle cell anemia
2003
E-Cadherin Gene Promoter Hypermethylation in Primary Human Gastric Carcinomas
2000
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
2002
Imaging of angiogenesis: from microscope to clinic
2003
Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
1999
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
Origins of circulating endothelial cells and endothelial outgrowth from blood
2000
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension
2007
Angiogenesis as a therapeutic target
2005 StandoutNature
Tumor Angiogenesis
2008 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
1999 Standout
Chimeric antigen receptor T-cell therapies for lymphoma
2017
A potent oral P‐selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease
2012
Dengue
2007 Standout
Modulation of endothelial cell activation in sickle cell disease: a pilot study
2001
Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice
2005
Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
2014 Standout
Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes
2003
Decrease of Very Late Activation Antigen-4 and CD36 on Reticulocytes in Sickle Cell Patients Treated With Hydroxyurea
1997
Young Adult Bone Marrow–Derived Endothelial Precursor Cells Restore Aging-Impaired Cardiac Angiogenic Function
2002
Plasma proteomics identifies a ‘chemokine storm’ in idiopathic multicentric Castleman disease
2018
CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells
1997
Hemostatic Alterations in Sickle Cell Disease: Relationships to Disease Pathophysiology
2001
Monoclonal antibodies to αVβ3 (7E3 and LM609) inhibit sickle red blood cell–endothelium interactions induced by platelet-activating factor
2000
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
2002
Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors
2000 Standout
In vitro reconstruction of a human capillary‐like network in a tissue‐engineered skin equivalent
1998
In vitro differentiation of endothelial cells from AC133-positive progenitor cells
2000
Introduction: anti-adhesion therapy in sickle cell disease
2000
Cytokine Storm
2020 Standout
Fetal hemoglobin in sickle cell anemia: relationship to erythrocyte adhesion markers and adhesion
2001
Tissue Engineering--Current Challenges and Expanding Opportunities
2002 StandoutScience
P-selectin mediates the adhesion of sickle erythrocytes to the endothelium
2001
Role of erythrocyte phosphatidylserine in sickle red cell–endothelial adhesion
2002
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
2018 Standout
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
2014
Evidence for HLA-related susceptibility for stroke in children with sickle cell disease
2000
Chimeric Antigen Receptor Therapy
2018 Standout
Transgenic sickle mice have vascular inflammation
2003
Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies
2015
Factors associated with survival in a contemporary adult sickle cell disease cohort
2014
Integrin-associated protein is an adhesion receptor on sickle red blood cells for immobilized thrombospondin
2001
Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin
2000
Mechanism of interaction of thrombospondin with human endothelium and inhibition of sickle erythrocyte adhesion to human endothelial cells by heparin
1999
Hydroxyurea corrects the dysregulated L-selectin expression and increased H2O2 production of polymorphonuclear neutrophils from patients with sickle cell anemia
2002
Reperfusion injury pathophysiology in sickle transgenic mice
2000
Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction
2003 Standout
Thrombophilia in sickle cell disease: the red cell connection
2001
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Beta-catenin mutations in human prostate cancer.
1998
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Genes Expressed in Human Tumor Endothelium
2000 StandoutScience
Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration
2003
Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion
2003
Works of Paul Browne being referenced
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation
2014
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
2006
CD36-positive stress reticulocytosis in sicle cell anemia
1996
Disturbance of plasma and platelet thrombospondin levels in sickle cell disease
1996
Circulating Activated Endothelial Cells in Sickle Cell Anemia
1997
Identification and functional assessment of endothelial P1H12
2001
Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT
2012
Removal of erythrocyte membrane iron in vivo ameliorates the pathobiology of murine thalassemia.
1997
The Molecular Pathobiology of Cell Membrane Iron: The Sickle Red Cell as a Model
1998
Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient survival
1997
A Novel Technique for Culture of Human Dermal Microvascular Endothelial Cells under either Serum-Free or Serum-Supplemented Conditions: Isolation by Panning and Stimulation with Vascular Endothelial Growth Factor
1997
Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time‐points reveals high levels of concordance between molecular and immunophenotypic approaches
2008